Page results
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
Information and advice for patients, relatives and carers about thoracic surgery.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
Advice on managing education for young people living with fatigue conditions.
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
Advice on relaxation techniques for young people living with fatigue conditions.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
File results
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023
-
FOI/2024/0347 - Paediatric elective surgical waiting lists
-
FOI/2024/0349 - Trust's operations and tele reporting services/ outsourced and insourced
-
FOI/2024/0354 - Staff details for estates and facilities
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues